SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 132 filers reported holding SCICLONE PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,787,631,000 | -7.7% | 174,403 | +17.6% | 0.20% | -25.1% |
| Q2 2016 | $1,937,125,000 | +2.2% | 148,325 | -13.9% | 0.26% | -0.8% |
| Q1 2016 | $1,895,322,000 | +18.5% | 172,302 | -0.9% | 0.26% | +10.9% |
| Q4 2015 | $1,599,871,000 | -16.0% | 173,899 | -36.6% | 0.24% | -38.7% |
| Q3 2015 | $1,903,580,000 | – | 274,291 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,663,281 | $16,300,000 | 9.19% |
| Nantahala Capital Management | 1,891,328 | $18,535,000 | 2.06% |
| Nine Chapters Capital Management LLC | 40,700 | $399,000 | 0.54% |
| MENTA CAPITAL LLC | 396,336 | $3,884,000 | 0.38% |
| Sapphire Star Partners LP | 30,439 | $298,000 | 0.34% |
| TFS CAPITAL LLC | 95,432 | $935,000 | 0.30% |
| Ativo Capital Management LLC | 123,428 | $1,210,000 | 0.30% |
| GLG Partners LP | 363,188 | $3,559,000 | 0.17% |
| GSA CAPITAL PARTNERS LLP | 240,013 | $2,352,000 | 0.13% |
| Bowling Portfolio Management LLC | 68,473 | $671,000 | 0.11% |